Published in Eur Arch Psychiatry Clin Neurosci on June 20, 2008
Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania. Int J Bipolar Disord (2015) 0.76
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry (2003) 3.74
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord (2000) 2.81
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry (2005) 2.32
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry (2005) 1.99
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry (2005) 1.56
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry (2002) 1.51
Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord (2000) 1.36
A factor analysis of the signs and symptoms of mania. Arch Gen Psychiatry (1998) 1.30
Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord (2001) 1.13
Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J Clin Psychiatry (1998) 1.07
Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J Affect Disord (2001) 1.02
Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord (1998) 1.02
Arguments for the genetic basis of the bipolar spectrum. J Affect Disord (2003) 1.00
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict (2006) 1.00
Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients. J Affect Disord (2006) 0.97
Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry (1999) 0.95
Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity. J Affect Disord (2003) 0.94
Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand (2006) 0.94
Symptom structure of acute mania: a factor study of the 24-item Brief Psychiatric Rating Scale in a national sample of patients hospitalized for a manic episode. J Affect Disord (2007) 0.90
Proposed multidimensional structure of mania: beyond the euphoric-dysphoric dichotomy. J Affect Disord (2003) 0.87
Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol (1996) 0.87
Ethnic differences in first clinical presentation of bipolar disorder: results from an epidemiological study. J Affect Disord (2004) 0.86
Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. J Affect Disord (1998) 0.86
Short-term variability of mood ratings in unipolar and bipolar depressed patients. J Affect Disord (1996) 0.85
Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations. J Affect Disord (2006) 0.80
Migration and manic-depressive illness. Compr Psychiatry (1983) 0.80
Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis. Psychopathology (2007) 0.77
The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. J Affect Disord (2006) 0.76
Is psychosis in DSM-IV mania due to severity? The relevance of selected demographic and comorbid social-phobic features. Acta Psychiatr Scand (2007) 0.75
Lithium toxicity profile: a systematic review and meta-analysis. Lancet (2012) 4.82
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord (2005) 2.58
Neural basis of autobiographical memory retrieval in schizophrenia. Br J Psychiatry (2012) 1.41
The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction (2003) 1.37
Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry (2002) 1.20
GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003). Joint Bone Spine (2012) 1.11
Trait-related decision-making impairment in the three phases of bipolar disorder. Biol Psychiatry (2011) 1.09
Quality of life among caregivers of individuals with affective disorders. J Affect Disord (2011) 1.05
Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci (2005) 1.04
Bilateral decrease in ventrolateral prefrontal cortex activation during motor response inhibition in mania. J Psychiatr Res (2008) 1.00
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness. BMC Psychiatry (2013) 0.97
Factors associated with rapid cycling in bipolar I manic patients: findings from a French national study. CNS Spectr (2008) 0.97
Lack of insight may predict impaired decision making in manic patients. Bipolar Disord (2008) 0.96
Differential responses to emotional interference in paranoid schizophrenia and bipolar mania. Psychopathology (2010) 0.95
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord (2003) 0.94
The role of anxious and hyperthymic temperaments in mental disorders: a national epidemiologic study. World Psychiatry (2010) 0.92
Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J Affect Disord (2009) 0.88
Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord (2006) 0.88
Investigation of impulsivity in a sample of treatment-seeking pathological gamblers: a multidimensional perspective. Psychiatry Res (2012) 0.87
Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French National Cohort. Compr Psychiatry (2008) 0.84
Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort. Psychopathology (2009) 0.84
Neuroprotective effect of riluzole in acute noise-induced hearing loss. Neuroreport (2005) 0.84
[Selecting material to develop an emotional Stroop test adapted to schizophrenia and bipolar disorders]. Can J Psychiatry (2008) 0.83
Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.83
[Psychosis revealing a silent celiac disease in a young women with trisomy 21]. Presse Med (2002) 0.83
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation. Addiction (2002) 0.83
Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases. Crit Rev Oncol Hematol (2011) 0.82
Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug. Eur Psychiatry (2007) 0.82
Insight in schizophrenia: from conceptualization to neuroscience. Psychiatry Clin Neurosci (2012) 0.82
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease. Curr Med Res Opin (2012) 0.81
Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability? World J Biol Psychiatry (2009) 0.80
Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians? Compr Psychiatry (2012) 0.80
Screening for bipolar disorder in patients consulting general practitioners in France. J Affect Disord (2010) 0.80
Characteristics and profiles of bipolar I patients according to age-at-onset: findings from an admixture analysis. J Affect Disord (2013) 0.80
The "Functional Remission of General Schizophrenia" (FROGS) scale: development and validation of a new questionnaire. Schizophr Res (2009) 0.80
[Screening and management of bipolar disorders: results]. Encephale (2010) 0.79
Sertindole for the treatment of schizophrenia. Expert Opin Pharmacother (2010) 0.78
Alpha absolute power measurement in panic disorder with agoraphobia patients. J Affect Disord (2013) 0.78
Late-onset bipolar illness: the geriatric bipolar type VI. CNS Neurosci Ther (2011) 0.78
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology (Berl) (2009) 0.77
Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading. CNS Neurosci Ther (2014) 0.77
Self-assessment and characteristics of mixed depression in the French national EPIDEP study. J Affect Disord (2012) 0.77
Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis. Psychopathology (2007) 0.77
Impact of an educational program on the management of bipolar disorder in primary care. Bipolar Disord (2011) 0.77
[Screening and management of bipolar disorders: methodology]. Encephale (2010) 0.77
Efficiency of brief interventions on alcohol-related risks in occupational medicine. Glob Health Promot (2013) 0.76
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol (2013) 0.76
Risks associated with gender differences in bipolar I disorder. J Affect Disord (2013) 0.76
An update on the treatment of bipolar depression. Expert Opin Pharmacother (2009) 0.76
The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. J Affect Disord (2006) 0.76
[Bipolar disorders and somatic comorbidities: a focus on metabollic syndrome, diabetes and cardiovascular disease]. Encephale (2012) 0.75
[Who is Called "Schizophrenic"?]. Therapie (2008) 0.75
Depression, anxiety and personality dimensions in female first-degree relatives of alcohol-dependent probands. Arch Womens Ment Health (2012) 0.75
DSM-IV diagnosis in depressed primary care patients with previous psychiatric ICD-10 bipolar disorder. J Affect Disord (2013) 0.75
[A randomized controlled study on the impact of pharmacoeducation on a French patient population with schizophrenic and schizoaffective disorders]. Can J Psychiatry (2010) 0.75
Association study between reward dependence and a functional BDNF polymorphism in adult women offspring of alcohol-dependent probands. Psychiatr Genet (2015) 0.75
Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France. Int Psychogeriatr (2011) 0.75
[Psychostimulants in the treatment of depression]. Presse Med (2012) 0.75
Correlates of first-episode polarity in a French cohort of 1089 bipolar I disorder patients: role of temperaments and triggering events. J Affect Disord (2010) 0.75
Fast alcohol consumption evaluation: a screening instrument adapted for French general practitioners. Alcohol Clin Exp Res (2006) 0.75